Deltaspharrma Profile
Key Indicators
- Authorised Capital ₹ 3.40 M
- Paid Up Capital ₹ 3.40 M
- Company Age 21 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 3305.62%
- Profit Growth 3406.82%
- Ebitda 2808.02%
- Net Worth 46.69%
- Total Assets 65.93%
About Deltaspharrma
Deltaspharrma Private Limited (DPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 March 2003 and has a history of 21 years and 11 months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Jagannath Organics India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.40 M and a paid-up capital of Rs 3.40 M, as per Ministry of Corporate Affairs (MCA) records.
Babuulal Jain and Ramsingh Rathod serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24210MH2003PTC139674
- Company No.
139674
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 2003
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Deltaspharrma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Babuulal Jain  | Director | 03-May-2022 | Current |
| Ramsingh Rathod | Director | 30-Jan-2022 | Current |
Financial Performance of Deltaspharrma.
Deltaspharrma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 3305.62% increase. The company also saw a substantial improvement in profitability, with a 3406.82% increase in profit. The company's net worth Soared by an impressive increase of 46.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deltaspharrma?
In 2021, Deltaspharrma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Toptime Consumer Private LimitedBabuulal Jain is a mutual person
Deltaspharma India Private LimitedBabuulal Jain is a mutual person
Magestic Premises Private LimitedBabuulal Jain is a mutual person
- Meridian Buildpro Private Limited
Babuulal Jain is a mutual person
- Padmavati Enterprises Private Limited
Babuulal Jain is a mutual person
- Divine Depute Private Limited
Babuulal Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Deltaspharrma?
Unlock and access historical data on people associated with Deltaspharrma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deltaspharrma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deltaspharrma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
